866-997-4948(US-Canada Toll Free)

Global T-Cell Immunotherapy Market Research Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

Notes:
Production, means the output of T-Cell Immunotherapy
Revenue, means the sales value of T-Cell Immunotherapy

This report studies T-Cell Immunotherapy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Adaptimmune
Altor Bioscience Corporation
Cellectis
Cell Therapy Catapult
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Abingworth
ARCH Venture Partners
Acorn Campus Ventures
Adaptimmune
AFA F?rs?kring
AGF Private Equity
AgonOx
Agreen Biotech
Aju IB Investment
Alaska Permanent Fund
Alexandria Ventures
Allos Therapeutics
Amgen
Applied Immune Technologies
Aquilo Capital Management
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of T-Cell Immunotherapy in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
CAR-T
TCR
TIL Therapies
Split by application, this report focuses on consumption, market share and growth rate of T-Cell Immunotherapy in each application, can be divided into
Hematological Malignancies
Solid Tumors
Others

Table of Contents

Global T-Cell Immunotherapy Market Research Report 2017
1 T-Cell Immunotherapy Market Overview
1.1 Product Overview and Scope of T-Cell Immunotherapy
1.2 T-Cell Immunotherapy Segment by Type
1.2.1 Global Production Market Share of T-Cell Immunotherapy by Type in 2015
1.2.2 CAR-T
1.2.3 TCR
1.2.4 TIL Therapies
1.3 T-Cell Immunotherapy Segment by Application
1.3.1 T-Cell Immunotherapy Consumption Market Share by Application in 2015
1.3.2 Hematological Malignancies
1.3.3 Solid Tumors
1.3.4 Others
1.4 T-Cell Immunotherapy Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of T-Cell Immunotherapy (2012-2022)

2 Global T-Cell Immunotherapy Market Competition by Manufacturers
2.1 Global T-Cell Immunotherapy Production and Share by Manufacturers (2015 and 2016)
2.2 Global T-Cell Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global T-Cell Immunotherapy Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers T-Cell Immunotherapy Manufacturing Base Distribution, Sales Area and Product Type
2.5 T-Cell Immunotherapy Market Competitive Situation and Trends
2.5.1 T-Cell Immunotherapy Market Concentration Rate
2.5.2 T-Cell Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global T-Cell Immunotherapy Production, Revenue (Value) by Region (2012-2017)
3.1 Global T-Cell Immunotherapy Production and Market Share by Region (2012-2017)
3.2 Global T-Cell Immunotherapy Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

4 Global T-Cell Immunotherapy Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global T-Cell Immunotherapy Consumption by Regions (2012-2017)
4.2 North America T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)
4.3 Europe T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)
4.4 China T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)
4.5 Japan T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)
4.7 India T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)

5 Global T-Cell Immunotherapy Production, Revenue (Value), Price Trend by Type
5.1 Global T-Cell Immunotherapy Production and Market Share by Type (2012-2017)
5.2 Global T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
5.3 Global T-Cell Immunotherapy Price by Type (2012-2017)
5.4 Global T-Cell Immunotherapy Production Growth by Type (2012-2017)

6 Global T-Cell Immunotherapy Market Analysis by Application
6.1 Global T-Cell Immunotherapy Consumption and Market Share by Application (2012-2017)
6.2 Global T-Cell Immunotherapy Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global T-Cell Immunotherapy Manufacturers Profiles/Analysis
7.1 Adaptimmune
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 T-Cell Immunotherapy Product Type, Application and Specification
7.1.2.1 CAR-T
7.1.2.2 TCR
7.1.3 Adaptimmune T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Altor Bioscience Corporation
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 T-Cell Immunotherapy Product Type, Application and Specification
7.2.2.1 CAR-T
7.2.2.2 TCR
7.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Cellectis
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 T-Cell Immunotherapy Product Type, Application and Specification
7.3.2.1 CAR-T
7.3.2.2 TCR
7.3.3 Cellectis T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Cell Therapy Catapult
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 T-Cell Immunotherapy Product Type, Application and Specification
7.4.2.1 CAR-T
7.4.2.2 TCR
7.4.3 Cell Therapy Catapult T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Juno Therapeutics
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 T-Cell Immunotherapy Product Type, Application and Specification
7.5.2.1 CAR-T
7.5.2.2 TCR
7.5.3 Juno Therapeutics T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Kite Pharma
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 T-Cell Immunotherapy Product Type, Application and Specification
7.6.2.1 CAR-T
7.6.2.2 TCR
7.6.3 Kite Pharma T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Novartis
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 T-Cell Immunotherapy Product Type, Application and Specification
7.7.2.1 CAR-T
7.7.2.2 TCR
7.7.3 Novartis T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Takara Bio
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 T-Cell Immunotherapy Product Type, Application and Specification
7.8.2.1 CAR-T
7.8.2.2 TCR
7.8.3 Takara Bio T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Unum Therapeutics
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 T-Cell Immunotherapy Product Type, Application and Specification
7.9.2.1 CAR-T
7.9.2.2 TCR
7.9.3 Unum Therapeutics T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Abingworth
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 T-Cell Immunotherapy Product Type, Application and Specification
7.10.2.1 CAR-T
7.10.2.2 TCR
7.10.3 Abingworth T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 ARCH Venture Partners
7.12 Acorn Campus Ventures
7.13 Adaptimmune
7.14 AFA F?rs?kring
7.15 AGF Private Equity
7.16 AgonOx
7.17 Agreen Biotech
7.18 Aju IB Investment
7.19 Alaska Permanent Fund
7.20 Alexandria Ventures
7.21 Allos Therapeutics
7.22 Amgen
7.23 Applied Immune Technologies
7.24 Aquilo Capital Management

8 T-Cell Immunotherapy Manufacturing Cost Analysis
8.1 T-Cell Immunotherapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of T-Cell Immunotherapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 T-Cell Immunotherapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global T-Cell Immunotherapy Market Forecast (2017-2022)
12.1 Global T-Cell Immunotherapy Production, Revenue and Price Forecast (2017-2022)
12.1.1 Global T-Cell Immunotherapy Production and Growth Rate Forecast (2017-2022)
12.1.2 Global T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global T-Cell Immunotherapy Price and Trend Forecast (2017-2022)
12.2 Global T-Cell Immunotherapy Production, Consumption , Import and Export Forecast by Regions (2017-2022)
12.2.1 North America T-Cell Immunotherapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe T-Cell Immunotherapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China T-Cell Immunotherapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan T-Cell Immunotherapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia T-Cell Immunotherapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India T-Cell Immunotherapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global T-Cell Immunotherapy Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global T-Cell Immunotherapy Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *